We are committed to rigorous science and innovative drug development, and we are excited to share our ongoing progress.
Showing 21-23 out of 23
Maetzel A, Smith MD, Duckworth EJ, Hampton SL, De Donatis GM, Murugesan N, Rushbrooke LJ, Li L, Francombe D, Feener EP, Yea CM
Duckworth EJ, Murugesan N, Li L, Rushbrooke LJ, Lee DK, De Donatis GM, Maetzel A, Yea CM, Hampton SL, Feener EP
Feener EP.
Curr. Diab. Rep. 2010 Aug; 10(4):270-5.
PMID:20535647